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Abstract  
 Numerous studies have reported the presence of several endocrine disrupting compounds (EDC) 
and pharmaceuticals and personal care products (PPCP) in wastewater effluents and 
consequently in natural water sources which serve as source water for drinking water utilities. 
However it is still unclear as to which of these compounds are important and need to be 
monitored. This paper proposes a new approach to identify indicators or surrogates to monitor 
these compounds in a watershed based on intensive sampling, analytical methods and statistical 
analysis. The watershed-level protocol involves identifying common patterns of occurrence in 
these trace chemicals and proposes indicators based on results of statistical analyses such as 
correlation, cluster and principal component analysis. The application of the indicators to predict 
concentration levels of other compounds is evaluated by developing regression models and 
determining significance of the models. Sampling was performed in the Assabet River in 
Massachusetts and 26 trace compounds and 3 tracers were targeted in the analysis. It was found 
that gadolinium served as an indicator for 14 other compounds. The application of this protocol 
will help drinking water utilities and regulators alike to more effectively utilize their allocated 
resources. 
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1.  Introduction: 
Burgeoning population growth and urban development have put a strain on the world’s 
freshwater resources. This in turn has put a strain on drinking water utilities, forcing them to 
examine new ways to meet the increasing demands which includes turning to lower quality 
waters. Furthermore, changing land use patterns and rapid urbanization have resulted in 
increased loading of trace contaminants from both point and non-point sources. Fluctuating 
surface water flows and continuously increasing wastewater discharges alter the percentage of 
wastewater present in the water sources, thereby affecting the quality of water available to 
drinking water utilities (Benotti et al. 2010; Kolpin et al. 2004). 
Recent studies have shown that wastewater treatment plants are a significant source of 
pharmaceuticals and other emerging contaminants in rivers (Glassmeyer et al 2005). The study 
involved sampling from ten locations and observed that the overall frequency of detection and 
total concentration (sum of the concentrations of all detected compounds) of the 110 compounds 
analyzed was greater in the effluent samples and samples downstream of the wastewater 
treatment plants (WWTP) compared to the upstream samples. Seventy eight of the compounds 
were detected at least once in the samples.  
There has been concern over the presence of these compounds in waters being used for drinking 
water, not due to their proven toxicity to human health(Snyder et al 2008), but mainly because of 
concern over chronic exposure and public and media perception. This has been augmented by 
extensive evidence that chemical constituents present in wastewater effluents can contribute to 
alteration in reproductive development in aquatic species, especially fish (WHO 2002; Ankley 
and Johnson 2004;Vos et al 2000). Generally the occurrence of these trace contaminants is 
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influenced by usage patterns, their physicochemical properties, the size of the community that 
the WWTP serves, etc.  
There have been many previous studies evaluating the viability of both conservative and non-
conservative tracers (Dickenson et al 2011; Basset et al 1995;Buerge et al 2003;Buerge et al 
2008;Buerge et al 2009;Clara et al 2004;Bundschuh et al 1993,Oppenheimer et al 2011), 
however the issue of co-occurrence and correlations have not been examined in a detailed 
manner. There is a need for such a study because the presence of a large number of contaminants 
and the lack of toxicity information complicates the process of determining which compounds 
are important and should be monitored (Murphy et al 2012). 
 This study proposes a protocol for choosing indicators or tracers to assess endocrine disrupting 
compounds/pharmaceuticals and personal care products (EDC/PPCP) concentrations in a 
watershed. This will help drinking water utilities to choose indicator compounds as a surrogate 
for the large number of trace contaminants. The protocol is based on intensive sampling, 
analytical techniques and statistical analysis to determine groups of compounds that occur 
together and then choosing an indicator for each group to shorten the list of contaminants to be 
measured. 
2.  Materials and Methods: 
2.1 Experimental Design 
To address the objective of the study, it was necessary to collect a new data set of key PPCPs and 
indicators in a watershed in the Northeastern United States. There have not been many 
occurrence studies that have been conducted for a watershed in the Northeast area. Although data 
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is available from prior studies, they did not have any of the attributes that were deemed 
necessary for this study. Only one watershed was used for developing the protocol since usage of 
the EDCs/PPCPs may be heavily influenced by geography and the demographic (Daughton 
2004). The list of analytes was chosen based on a literature review and selecting compounds 
which were reported to be detected frequently in the United States and were toxicologically 
relevant. Sucralose, gadolinium and iodine were selected because of their reported conservative 
nature and their potential use as tracers (Loos et al 2009;Ferrer and Thurman 2010; Duirk et al 
2011). Total gadolinium has been studied as a tracer by many groups (Lawrence et al 2009; 
Lawrence et al 2010; Verplanck et al 2005). It is used as a contrast agent in Magnetic Resonance 
Imaging (MRI) in the form of an organic complex and is considered to be non-biodegradable 
(Kümmerer and Helmers 2000). Sucralose is a widely used artificial sweetener and has also been 
reported to be persistent in nature (Soh et al 2011). Natural iodine is present in surface waters but 
there are also anthropogenic sources for iodine such as iodinated contrast agents used in medical 
imaging (Duirk et al 2011). Total iodine could be conservative and hence it has been proposed as 
a tracer.   
2.2 Assabet Watershed: 
The Assabet River begins at Westborough, MA 20 miles west of Boston. It’s headwaters 
originate at the George.H.Nichols Dam which is the outlet from the Assabet River Reservoir also 
known as the A1 Impoundment. The river flows northeast through Northborough, Marlborough, 
Hudson, Stow, Maynard and Concord and confluences with the Sudbury River to form the 
Concord River.  The main stem of the river receives discharges from four major wastewater 
treatment plants (WWTP): Westborough WWTP, Marlborough West WWTP, Hudson WWTP 
and Maynard WWTP. Many tributaries flow into the Assabet River, the largest of which is the 
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Nashoba brook. There are three USGS gages- one upstream of the Hudson WWTP discharge, 
one upstream of the Maynard WWTP discharge and one on Nashoba Brook (SuAsCo Watershed 
Year 2001 Water Quality Assessment Report).  
2.3 Sampling Design and Methods: 
The Assabet River was chosen as the study watershed because it is heavily impacted by WWTP 
effluent discharge (average of 50% wastewater effluent at median flow conditions). A nutrient 
TMDL was completed in 2004 for the river and requires that WWTPs remove phosphorous 
down to 0.1 mg/L in their effluents since the river is considered eutrophic, a condition attributed 
phosphorous from WWTP effluents and in river-bottom sediments (SuAsCo Watershed Year 
2001 Water Quality Assessment Report). Grab samples were collected at sites along the Assabet 
River which included upstream and downstream samples from the wastewater treatment plants 
(WWTP) and 3 tributary sites.  Six sampling campaigns were conducted from August 2011 to 
May 2012(Table 2).USGS flow data was recorded from the USGS gaging station at 
Maynard,MA. Composite effluent samples were also collected but the results are not included in 
this study. Conductivity, pH and temperature were measured on site and are shown in Appendix 
6.2.  
All samples were collected in amber bottles and filtered using 2.7 µm GF/D filters (Whatman
®
) 
prior to analysis. The EDC/PPCP samples were preserved with 500 mg/L sodium azide and 25 
mg/L ascorbic acid. The samples for tracer analysis were preserved using 2 % nitric acid.  
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Figure 1: Sampling Locations 
 
 
To Concord 
River 
 6 
 
Table 1: List of Wastewater Treatment Plants discharging into the Assabet River 
Facility Capacity(MGD) Typical 
Flows(MGD) 
Treatment Train 
Westborough 
WWTP 
20 6 Primary Sedimentation, 
Activated Sludge, 
Secondary Sedimentation, 
Phosphorous Removal, UV 
Disinfection 
Marlborough West 
WWTP 
2.95 2.5 Primary Sedimentation, 
Activated 
Sludge(Nitrification), 
Secondary Sedimentation, 
Phosphorous Removal 
(BluePro),UV Disinfection 
Hudson WWTP 2.65 2.65 Primary Sedimentation, 
Activated Sludge (2 stage 
Nitrification),Secondary 
Sedimentation,Dissolved 
Air 
Flotation(FeCl),Chlorine 
Disinfection 
Maynard WWTP 1.1 1 Primary Sedimentation, 
Rotary Biological 
Contactor, Secondary 
Sedimentation, CoMag, 
Tertiary Clarification, 
Chlorine Disinfection 
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2.4 Analytical Methods: 
Gadolinium and iodine were measured using inductively coupled plasma-mass spectrometry 
(ICPMS). Samples were analyzed using an Elan DRC-e Perkin Elmer ICP-MS. The instrument 
was tuned for maximum sensitivity for magnesium, indium and uranium while maintaining oxide 
production below 2% (CeO/Ce). The instrument was calibrated using standards obtained from 
Perkin Elmer.  
The EDCs/PPCPs were measured according to Method 18CD (Vanderford et al 2012). Analytes 
were extracted using HLB Oasis® 200 mg columns. The columns were sequentially 
preconditioned using 3 mL dichloromethane (DCM), 5 mL methanol (MeOH) and 7mL Milli-Q
®
 
water (H2O). Samples were spiked with internal standards that were available (Table 3). Five 
hundred milliliter samples were then loaded onto the cartridges at 10 mL/min after which the 
cartridges were rinsed with 3 mL H2O and 5 mL of 5% MeOH. The cartridges were dried for 40 
minutes under vacuum after which the analytes were eluted with 6 mL MeOH followed by 4 mL 
MeOH/DCM (70:30). The eluate was then dried under a gentle stream of nitrogen at 35 °C to a 
volume of 0.5 mL and then volumed upto 1 mL with MeOH.  
Separation and detection of analytes were achieved using ultra performance liquid 
chromatography followed by tandem mass spectrometry (UPLC-MS-MS). A Waters Acquity 
UPLC separation module was used for liquid chromatography and a Quattro Premier XE 
Micromass was used for mass spectrometry. Analytes were separated using an Acquity BEH C18 
(1.7 µm, 2.1 X 50 m) UPLC column. Both ESI (+) and ESI (–) modes were used for detection.  
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Table 2: Sampling dates with corresponding flow data 
Sampling Date 
(MM/YYYY) 
Flow at Maynard USGS 
Gage(cfs) 
                08/2012 121 
                11/2011  303 
                02/2012  241 
03/2012* 182 
04/2012* 86 
05/2012* 331 
*- Datasets used for calibration of the regression models. 
Table 3: List of Analytes measured using UPLC-MS-MS 
Analyte Compound Category 
Acetaminophen Analgesic 
Atenolol* Beta-blocker 
Atorvastatin* Anti-cholestrol 
Caffeine Coffee 
Cimetidine Ulcers& heart burn 
treatment 
Ciprofloxacin Antibiotic 
Cotinine Nicotine metabolite 
DEET Insect repellant 
Diclofenac Anti-inflammatory 
Diltiazem Calcium-channel blocker 
Diphenhydramine Antihistamine 
Estradiol Hormone 
Estrone Hormone 
Furosemide Loop diuretic 
Gemfibrozil Anticholesterol 
Ibuprofen Anti-inflammatory 
analgesic 
Miconazole Antifungal 
Naproxen* Analgesic 
Primidone Anti-epileptic 
Propanolol* Beta-blocker 
Ranitidine* Ulcers & heart burn 
treatment 
Salbutamol 
 
Asthma Treatment 
Sucralose Artificial Sweetener 
Sulfamethoxazole* Antibiotic 
TCEP Fire retardant 
Trimethoprim* Antibiotic 
Warfarin Blood thinner 
*-Compounds with internal standards. Other compounds were calibrated using external standards                                                                            
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2.5 Statistical Methods: 
Hierarchical cluster analysis (CA) was used to identify patterns of co-occurrence in the 
compounds. The agglomerative Ward’s Method was used. This method aims at minimizing the 
variance among compounds in a group. The significance of the clustering was determined by 
Sneath’s Index; this represents the significance on two levels of distance measure 
D/Dmax:1/3Dmax and 2/3Dmax (Astel et al 2007; Einax et al 1998). Groups remaining after 
subjecting the clusters to the Sneath’s Indices- are considered significant. The data were 
normalized (means equal to 0 and standard deviation equal to 1) since the concentration ranges 
were different for the compounds. Also the squared Euclidean distance matrix was used to 
measure similarity among clusters, which gives more weight to distance between variables.  
Principal component analysis (PCA) is a commonly used statistical analysis to identify 
underlying patterns in data. PCA aims to identify principal components that explain variances 
between compounds and between monitoring data (sampling dates and locations). PCA also 
quantifies the significance of each of the components identified in terms of percentage of 
variance explained by each component. A correlation matrix was used for the analysis due to the 
differing ranges of the compounds 
Correlation coefficients and scatterplots were also generated between compounds to assess the 
degree of correlation within compounds based on linear fits. The groups generated by CA and 
PCA were subjected to another level of validation using the criteria of a Pearson’s coefficient > 
0.6. Regression models (RM) were also generated for the groups by splitting the 6 datasets into 
two groups - calibration and validation data.                                                                                                                                                       
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3.  Results and Discussion 
3.1  Occurrence  
The in-stream concentration levels of the target analytes are shown as box and whisker plots 
(Figure 2).  A summary of the data is also shown in Table 4. Most of the analyte concentrations 
are within the range of previously reported values (Table 4).  Cimetidine, ciprofloxacin and 
furosemide were measured at higher concentrations than previously reported. This might be 
because there have not been many studies that have measured the concentration of these 
compounds in surface waters.  
The maximum sucralose and gadolinium concentrations measured, excluding outliers, were 4020 
ng/L and 75 ng/L respectively which are well within the range of previously reported literature 
values (Mawhinney et al 2011; Verplanck et al 2005). There haven’t been many studies looking 
at total iodine concentrations in surface water and hence a comparison could not be made.  
3.2  Statistical Analysis 
The data were analyzed using CA, PCA and correlation analysis. Outliers were identified and 
omitted after examining the data and determining if any of the other compounds exhibited a high 
concentration at that sampling point. If it was found to be a single occurrence, the outlier was 
excluded from the analysis.  
CA results can be represented in the form of a hierarchical dendogram (Figure 3). As seen in the 
figure, CA indicates 4 clusters according to the more restrictive criterion of the Sneath’s index 
(Dmax/3). Since this is only an exploratory technique, the results of PCA were also examined 
determine if the results were similar. The first two principal components (PC) identified 
accounted for 48% of the total variance in the data with PC1 accounting for 37% of the total 
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variance in the data and PC2 accounting for 11% of the total variance. PCA looks at components 
causing the variance in data and hence groups compounds based on whether similar components 
are causing the variance in the data. Thus PCA provides a grouping of compounds based on 
factors affecting the correlation in data- like usage and attenuation pathways. A loading plot of 
PC1 vs PC2 (Figure 4), shows a cluster of compounds in the bottom right corner, similar to one 
of the clusters identified by CA. All the compounds clustered together by CA are also clustered 
together in PCA. However ibuprofen, ranitidine and cimetidine are also clustered along with the 
13 compounds clustered by CA. PCA is more sensitive to variation in data and hence more 
accurate than CA which can be seen by the spread between other compounds in the loading plot 
that were clustered together by CA. Scatter plots and Pearson’s correlation coefficients indicate a 
good degree of correlation between the compounds in the cluster indicated by PCA (Figure 5).  
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Figure 2: Box and Whisker Plots 
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Table 4: Summary of Reported Literature Values and Measured Concentrations (All values are in ng/L) 
 Summary of Measured Concentrations Reported Literature Values 
Compound Mean Median Maximum Mean Median Maximum References 
Acetaminophen 4.9 4.2 21.3 
 
- 2.5;10 10000 Anderson et al 2010; 
Kolpin et al 2002; 
Holloway and Rush 2010 
Atenolol 55.5 37.8 264 - 2.3;470 1800 Anderson et al 2010;Benotti et 
al 2009 
Atorvastatin 6.3 1.6 49 - 0.8 79 Anderson et al 2010;Benotti et 
al 2009; Klečka et al 2010 
Caffeine 17.4 13.2 67.1 31.6 14;280 2700 Anderson et al 2010;Klečka et 
al 2010; Holloway and Rush 
2010; Singh et al 2010 
Cimetidine 212 33 2.7*10
3 
11.8 - 53 Klečka et al 2010 
Ciprofloxacin 139 66.7 680 - 20 180 Kolpin et al 2002; Loper at al 
2007 
Cotinine 3.8 2.7 21 7.4 3 50 Klečka et al 2010; Holloway 
and Rush 2010 
DEET 20.7 10.6 89.5 - 10;37;185 1700 Anderson et al 2010;Benotti et 
al 2009;  Holloway and Rush 
2010; Singh et al 2010 
Diclofenac 3.7 0.8 36.8 33.1 1.1;21.5 230 Anderson et al 2010;Benotti et 
al 2009;Klečka et al 2010 
Diltiazem 3.6*10
4
 1.5*10
3 
5*10
5 
8.4 <12 106 Klečka et al 2010;Kolpin et al 
2002 
Diphenhydramine 22.6 11 108 - - -  
Estradiol 7.9 5.1 28.8 - 1.4;17 74 Anderson et al 2010;Anderson 
et al 2012;Benotti et al 
2009;Singh et al 2010 
Estrone 14.1 11.1 88.6 - 0.3;3 112 Anderson et al 2010;Benotti et 
al 2009;Kolpin et al 2002; 
Holloway and Rush  
2010;Singh et al 2010 
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Table 4 (contd.) 
 Summary of Measured Concentrations Reported Literature Values 
Compound Mean Median Maximum Mean Median Maximum References 
Furosemide 40.5 5.5 607 - - 63 Anderson et al 2010 
Gemfibrozil 12.3 4.6 129 15.7 1.4;2.2;610 4300 Anderson et al 2010;Benotti et al 
2009;Klečka et al 2002; 
Holloway and Rush 2010 
Gadolinum 32.9 29.5 125.6 40.8 41 76 Verplanck et al 2005 
Ibuprofen 7.2 3.8 43.5 72.9 3.25;15 5850 Anderson et al 2010; Klecka et al 
2010;Loraine and Pettigrove 
2006; Holloway and Rush 2010 
Iodine 5*10
3 
2.9*10
3 
1.8*10
4 
- - - - 
Miconazole 4.5 1.2 27.4 - - -  
Naproxen 5.3 3.3 29.1 63 0.9;23 860 Anderson et al 2006;Benotti et al 
2009;Klečka et al 2010 
Primidone 18.4 6.9 139  - 130 Anderson et al 2010 
Propanolol 15.5 6.3 110  - -  
Ranitidine 34.8 12 277  - -  
Salbutamol 4.2 2.7 24.6  - -  
Sucralose 3.5*10
3 
2*10
3 
2.4*10
4
    Mawhinney et al 2011 
Sulfamethoxazole 301 137 1.6*10
3 
 26 4;12;295 Anderson et al 2010;Benotti et al 
2009;Klečka et al 2010;Kolpin et 
al 2002;Loper et al 2007; 
Holloway and Rush 2010 
TCEP 29.6 19.2 285  86 35;400 Anderson et al 2010;Benotti et al 
2009;Klečka et al 2010 
Trimethoprim 75.3 26 644  16.1 0.8;13;44.5 Anderson et al 2010;Benotti et al 
2009;Klečka et al 2010;Kolpin et 
al 2002 
Warfarin 4.4 2.3 34.5  - -  
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Figure 3: Heriarchical Dendogram  using Ward's Method and Squared Euclidean Matrix
 
Figure 4: Loading Plot from PCA Analysis (PC1 vs PC2) 
The cluster (shown by the circle) is similar to the 13 member cluster indicated in Figure 3 
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3.3 Indicators 
Several different approaches have been taken to choose indicators for EDCs/PPCPs, some based 
on toxicological relevance and detection frequencies (Dickenson et al 2011), some based on 
mass balance and determination of percentage of wastewater (Lawrence et al 2010; Verplank et 
al 2005; Verplanck et al 2010; Bau and Dulski 1996) and some based on common treatment 
pathways for different compounds (Drewes et al 2008). This study focusses on correlation 
between the compounds and identifying indicators based on statistical analyses such as PCA and 
CA. 
The use of gadolinium as an indicator was evaluated by means of  its correlation with 14 other 
compounds. Other studies have incorporated the use of gadolinium as a tracer (Lawrence et al 
2010;Verplanck et al 2005;Künnemeyer et al 2009; Kümmerer et al 2000; Möller et al 2000), but 
these have focused on mass balance and its use in determining percentage of wastewater in a 
sample rather than its correlation with other compounds.  
Regression models were developed for the 15 compounds in the group (Table 5) using 
gadolinium as a predictor.  It was found that quadratic models fit better than linear models and 
therefore quadratic models were used for calibration and prediction.  The quadratic model is 
shown in equation 1 where a, b and c are estimation parameters; I is the concentration of the 
indicator and C is concentration of the compound being predicted. R
2 
values and p-values were 
calculated for the quadratic regression models (Table 6). A comparison of predicted and 
measured concentrations is shown as plots (Appendix 6.4). As seen, the p-values are consistently 
well below 0.0015 and the R
2
 values are greater than 0.6 for many compounds and greater than 
0.5 for a few.  These values indicate that the models developed are highly significant. 
Cimetidine, diclofenac, furosemide, propanolol and salbutamol showed a high degree of 
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correlation with gadolinium and the model results reflected the same. However, the regression 
model for trimethoprim had a poor R
2
 value and p-value. However it was retained because it was 
clustered together with the other compounds in both CA and PCA. Also, sulfamethoxazole and 
trimethoprim are often prescribed together and hence tend to correlate well.  
             Equation 1 
In examining the clustering of the compounds, most of the clustering was found to be influenced 
by usage. As mentioned before, sulfamethoxazole and trimethoprim are sulfonamide antibiotics 
prescribed together in the ratio 5:1. All the compounds in the 15 member group are 
pharmaceuticals and their primary source in the watershed would be from WWTP discharges. 
Clustering of sulfamethoxazole, trimethoprim, diphenhydramine and diltiazem has also been 
reported in another study (Glassmeyer et al 2005).  In the same study it was also observed that 
caffeine, even though considered to be an indicator of wastewater contribution to receiving 
waters, did not correlate well with any other compounds. As the statistical analyses show, 
caffeine does not correlate well with the other compounds in this study also. This might be due to 
the fact that caffeine has both natural and anthropogenic sources.  Estradiol and estrone also have 
multiple sources including WWTP discharges, excretion from animals after synthesis and 
metabolism and hence might not correlate well with other compounds which have mainly 
anthropogenic sources (Mompelat et al 2009). 
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Table 5: List of Indicators 
Indicator Compounds 
Gadolinium Atenolol 
Cimetidine 
Cotinine 
Diclofenac 
Diltiazem 
Diphenhydramine 
Furosemide 
Primidone 
Propanolol 
Ranitidine 
Salbutamol 
Sucralose  
Sulfamethoxazole 
Trimethoprim 
Acetaminophen Acetaminophen  
Atorvastatin Atorvastatin  
Caffeine Caffeine  
Ciprofloxacin Ciprofloxacin  
DEET DEET  
Estradiol Estradiol  
Estrone Estrone  
Gemfibrozil Gemfibrozil  
Ibuprofen Ibuprofen  
Miconazole Miconazole  
Naproxen Naproxen  
TCEP TCEP  
Warfarin Warfarin  
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Figure 5: Scatterplots and Pearson's Coefficient for compounds in Group 1                                                                                              
The diagonal represents histogram distributions for each compound. Below the diagonal are the scatter plots with linear fits. The 
numbers above the diagonal are Pearson’s Coefficients 
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Table 6: Quadratic Regression Model Results 
Compound Predictor p-value R
2
 Estimation Parameters 
a b c 
Atenolol Gadolinium 2.1*10
-5 
0.59 0.01 0.57 1.61 
Cimetidine Gadolinium 1.0*10
-7 
0.98 0.27 -14.4 199 
Cotinine Gadolinium 1.4*10
-6 
0.61 0 -0.043 2.46 
Diclofenac Gadolinium 5.5*10
-7 
0.88 0 -0.15 3.16 
Diltiazem Gadolinium 4.4*10
-6 
0.63 38.6 -1153 2.6*10
4 
Diphenhydramine Gadolinium 2.1*10
-4 
0.50 0 0.64 -5.6 
Furosemide Gadolinium 8.3*10
-8 
0.96 0.05 -2.77 34.9 
Primidone Gadolinium 4.3*10
-5 
0.52 0 0.11 2.8 
Propanolol Gadolinium 6.2*10
-7 
0.82 0 -0.03 2.32 
Ranitidine Gadolinium 8.0*10
-9 
0.92 0.02 -0.56 2.46 
Salbutamol Gadolinium 3.2*10
-7 
0.80 0 0.01 0.45 
Sucralose Gadolinium 6.8*10
-4 
0.50 0.01 1.61 -19.5 
Sulfamethoxazole Gadolinium 1.9*10
-6 
0.63 0.13 -5.84 198 
Trimethoprim Gadolinium 0.7 0.04 0 -0.18 8.33 
4.  Conclusion 
The protocol developed in this study utilizes intensive sampling, analytical techniques, statistical analyses, and 
subsequent validation to choose indicators for emerging organic contaminants. The initial list of contaminants 
can be arrived at based on limited knowledge of usage patterns, toxicology information, detection frequencies 
and detection ratios. Based on the statistical protocol used in this study, gadolinium was chosen as an indicator 
for 14 other compounds. The criteria for choosing an indicator are good detection frequency and ease of 
measurement. Gadolinium is easy to measure (no tedious sample preparation and concentration required) and its 
use greatly reduces analysis time and expense. It is also recommended that other compounds that do not 
correlate well with each other, and that have known toxicological relevance based on concentration levels and 
are detected frequently, be analyzed along with gadolinium to ensure that there is no loss of information that 
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might indicate deterioration in water quality. In this case it would be advisable to measure gadolinium, 
atorvastatin, ciprofloxacin, DEET, estradiol, estrone, gemfibrozil, miconazole, naproxen, TCEP and warfarin. 
Acetaminophen was not measured at concentrations that were toxicologically relevant and caffeine is relatively 
less toxic and has plenty of natural sources and hence these compounds were excluded from the shortlist. Iodine 
did not correlate well with any of the other compounds and hence it might not be as helpful as a tracer. 
Sucralose correlated well with the 14 member cluster but since gadolinium was in the same cluster and is easier 
to measure, gadolinium was chosen over sucralose. However if the resources to measure gadolinium are not 
available, sucralose can be used as an alternate indicator. The correlation in general seems to be influenced by 
usage of the compounds. It must be kept in mind that this is a watershed-level protocol and hence the indicators 
apply only to the particular watershed, in this case, the Assabet watershed. This correlation might exist in other 
watersheds too but can only be known by doing similar measurements in the watershed of interest. This 
protocol will help drinking water treatment plant operators and regulators alike to invest their resources more 
effectively to assess the presence of EDC/PPCPs in surface and drinking water.  
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6 Appendix 
6.1  Liquid Chromatography-Mobile Phase Gradient 
The mobile phases for ESI (+) were Solvent A: 0.05% aqueous formic acid with 1 g ammonium formate and 
Solvent B: Methanol/ Acetonitrile (1:1) with 0.1% formic acid at a flow rate of 0.35 mL/min. The gradient 
program started with 3% solvent B, increased linearly to 95% solvent B in 10 minutes, and stayed at 95% 
solvent B for 6 minutes after which it was brought back to 3% solvent B in 1 minute and kept at 3% solvent B 
for 8 minutes. The total run time was 25 minutes. The mobile phases for ESI (–) were Solvent A: 40 mg/L 
aqueous ammonium acetate and Solvent B: 100% methanol at a flow rate of 0.4 mL/min. The gradient program 
started with 3% solvent B , increased linearly to 25% solvent B in 1 minute, then increased linearly to 99% 
solvent B in 5 minutes, stayed at 99% solvent B for 5 minutes, then decreased back to 3% solvent B in 3 
minutes and was kept at that composition for 7 minutes. The total run time was 20 minutes.   
6.2 Sampling Data  
 
November 16th 2011 
Location Time Date pH Conductivity(µS/cm) Temperature(°C) 
Westborough WWTP Effluent 10:15 AM 11/16/2011 6.65   
Marlborough West WWTP Effluent 11:55 AM 11/16/2011 6.71 1612 15.1 
Hudson WWTP Effluent 12:55 AM 11/16/2011 6.75 1836 13.2 
Maynard WWTP Effluent 1:30 PM 11/16/2011 6.93 670 15.7 
River Sample above Westborough 
WWTP 
10:50 AM 11/16/2011 6.73 191.7 10.2 
River Sample below Westborough 
WWTP 
11:05 AM 11/16/2011 6.6 277 12 
River Sample below Marlborough 
WWTP 
12:10 AM 11/16/2011 6.55 271.2 12.8 
River Sample below Hudson WWTP 2:25 PM 11/16/2011 6.79 414.8 12.4 
River Sample below Maynard WWTP 1:55 PM 11/16/2011 7.03 386.3 12.2 
River Sample for Agricultural Runoff 3:50 PM 11/16/2011 6.76 431.5 12.2 
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February 6th 2012 
Location Time Date pH Conductivity(µS/cm) Temperature(°C) 
Marlborough West WWTP Effluent 10:10 AM 2/6/2012 6.1 1347 9.4 
Maynard WWTP Effluent 11:45 AM 2/6/2012 5.97 332 9.8 
River Sample above Westborough WWTP 9:25 AM 2/6/2012 5.9 197 3.4 
River Sample below Westborough WWTP 9:40 AM 2/6/2012 5.9 670 5 
River Sample below Marlborough WWTP 10:25 AM 2/6/2012 5.93 283 5 
River Sample below Hudson WWTP 11:00 AM 2/6/2012 5.9 336.7 4.8 
River Sample below Maynard WWTP 12:05 PM 2/6/2012 5.82 405.2 3.9 
River Sample for Agricultural Runoff 2:50 PM 2/6/2012 5.2 442 5.1 
Nashoba Brook 12:55 PM 2/6/2012 5.6 431 2 
River sample-No Dilution Below Maynard 1:30 PM 2/6/2012 6 433.5 5 
 
 
 
 
February 28th 2012 
Location Time Date pH Conductivity(µS/cm) Temperature(°C) 
Upstream Westborough 9:10 AM 2/28/2012 5.8 194.3 5.3 
Downstream Westborough  9:40 AM 2/28/2012 5.7 695 7.3 
Westborough WWTP Effluent 9:45 AM 2/28/2012 7.06 1132 8 
River Sample for Agricultural Runoff 10:00 AM 2/28/2012 5.1 435.7 4.8 
Tributary 2 10:30 AM 2/28/2012 5.3 375.5 4 
Marlborough West WWTP Effluent 10:50 AM 2/28/2012 6.57 1433 10.4 
Upstream Marlborough 11:10 AM 2/28/2012 5.3 487.2 5.4 
Downstream Marlborough 11:20 AM 2/28/2012 5.47 540 6.5 
Upstream Hudson 12:00 PM 2/28/2012 4.8 434.6 5.9 
Downstream Hudson 12:20 PM 2/28/2012 5.8 434.8 6.1 
Maynard WWTP Effluent 12:40 PM 2/28/2012 6.17 675 10.6 
Downstream Maynard 1:10 PM 2/28/2012 6.32 372.2 5.7 
River sample-No Dilution Below Maynard 1:30 PM 2/28/2012 6.46 367.5 7 
Nashoba Brook 2:00 PM 2/28/2012 5.5 374 5.6 
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May 10th 2012 
Location Time Date pH Conductivity(µS/cm) Temperature(°C) 
Upstream Westborough 9:30 AM 5/10/2012 6.7 149.6 15.4 
Downstream Westborough  9:45 AM 5/10/2012 6.97 451.9 14.5 
Westborough WWTP Effluent 10:00 AM 5/10/2012 7.3 1178 21.3 
River Sample for Agricultural Runoff 10:10 AM 5/10/2012 6.81 240 13.3 
Tributary 2 10:35 AM 5/10/2012 6.48 208.2 13.7 
Marlborough West WWTP Effluent 10:55 AM 5/10/2012 5.74 935 5.2 
Upstream Marlborough 11:10 AM 5/10/2012 6.93 340 14.6 
Downstream Marlborough 11:20 AM 5/10/2012 6.24 353.1 14.6 
Hudson WWTP Effluent 11:50 AM 5/10/2012 7.14 1291 14.6 
Upstream Hudson 11:55 AM 5/10/2012 6.51 300.7 14.9 
Downstream Hudson 12:05 PM 5/10/2012 6.59 298 15 
Maynard WWTP Effluent 12:35 PM 5/10/2012 6.72 519 15.2 
Downstream Maynard 12:45 PM 5/10/2012 6.87 314.3 15.9 
Nashoba Brook 1:00 PM 5/10/2012 6.27 215.3 14.9 
 
 
 
 
 
6.3 Analytical Results 
 
The results of the UPLC-MS and ICP-MS analysis are shown below in ng/L. NA values are non-detects or 
negative values due to blank subtraction. 
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August 21st 2011 
 
 Sampling Location Diphenhydramine Estradiol Estrone Furosemide Gemfibrozil Ibuprofen Miconazole Naproxen Primidone Propanolol 
Westborough Effluent 68.3 NA NA 238.6 145.7 70.6 7.3 37.6 59.1 71.0 
Marlborough Effluent 137.0 NA NA 246.5 12.3 23.0 0.3 54.8 51.1 62.7 
Hudson Effluent 41.0 16.7 NA 51.7 63.1 29.6 NA 19.4 130.5 37.5 
Maynard Effluent 281.3 16.7 7.9 392.4 457.1 156.5 0.4 664.2 107.2 93.0 
Upstream Westborough NA NA NA 0.3 0.1 1.6 NA NA NA NA 
Downstream Westborough 78.0 NA NA 231.3 128.7 43.5 0.0 19.4 55.5 49.0 
Downstream Marlborough 26.7 5.6 NA 22.5 75.3 24.6 NA 17.5 16.5 11.1 
Downstream Hudson 50.4 17.2 NA 61.6 59.0 26.7 NA 13.4 139.5 27.7 
Downstream Maynard 8.2 NA NA 0.3 2.6 9.8 NA 4.8 NA 2.6 
  
 Sampling Location Acetaminophen Atenolol Atorvastatin Caffeine Cimetidine Ciprofloxacin Cotinine DEET Diclofenac Diltiazem  
Westborough Effluent NA 194.3 11.3 28.1 537.8 NA 9.1 NA 23.5 7025.7  
Marlborough Effluent NA 1190.0 5.3 0.9 423.1 574.5 8.5 3.2 9.3 13845.3  
Hudson Effluent 9.7 201.8 NA NA 3.3 NA 10.7 27.3 22.7 10910.8  
Maynard Effluent 31.1 1667.3 56.8 290.5 NA 360.7 49.4 151.3 81.1 16296.8  
Upstream Westborough NA NA 0.6 38.2 NA NA 2.2 11.1 0.0 20.8  
Downstream Westborough NA 123.0 12.2 NA 445.6 NA 7.3 51.7 18.4 8211.4  
Downstream Marlborough NA 66.6 4.3 NA 61.3 0.4 4.8 39.1 6.2 2170.8  
Downstream Hudson NA 118.7 1.2 NA 3.8 NA 9.1 58.5 18.5 14106.9  
Downstream Maynard NA 16.4 0.9 44.1 2.9 NA 3.0 22.0 0.3 513.2  
 Sampling Location Ranitidine Salbutamol Sulfamethoxazole TCEP Trimethoprim Warfarin Gadolinium Iodine 
Westborough Effluent 253.1 15.3 1937.2 30.6 492.1 9.5 72.7 22370 
Marlborough Effluent 136.5 11.5 1303.0 45.3 364.1 13.9 93.4 85810 
Hudson Effluent NA 14.9 1836.4 49.2 74.3 NA 110.9 10889 
Maynard Effluent NA 13.4 1882.7 45.2 463.8 1.4 21.9 10986 
Upstream Westborough NA NA NA 7.6 0.8 1.3 5.6 4428.4 
Downstream Westborough 168.3 9.3 1281.8 102.6 316.8 10.3 55.6 18187 
Downstream Marlborough 5.8 2.4 467.6 43.6 57.3 3.9 35.5 11862 
Downstream Hudson NA 14.5 1472.4 285.3 58.4 3.8 62.9 6053.3 
Downstream Maynard 0.7 0.6 96.2 20.5 5.7 2.5 20.1 8748.5 
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November 16th 2011 
 
Sampling Location Diphenhydramine Estradiol Estrone Furosemide Gemfibrozil Ibuprofen Miconazole Naproxen Primidone Propanolol 
Marlborough Effluent 59.5 16.6 15.7 50.2 50 18.2 1.7 25.9 20.8 78.6 
Hudson Effluent 27.4 15.6 10.8 42.6 159.1 19 1.1 29.1 35.2 53.9 
Maynard Effluent 6 40.5 4.5 141.1 29.2 43.7 0.8 3633.5 NA 68.9 
Upstream Westborough 3.4 20.3 13.8 2.8 7.5 21.7 1.0 29.1 1.3 6.1 
Downstream Westborough 8.3 17.7 10.6 20.6 0.8 10.5 0.8 0.8 6.7 24 
Downstream Marlborough 5 15.3 15.9 9.6 1.6 3.7 1.3 1.8 2.4 9 
Downstream Maynard 0.9 NA 11.6 NA NA 0.2 1.2 0.5 NA 1.2 
Downstream Hudson 5.1 12.2 12.6 4.5 7.1 2.7 0.7 2.3 4.8 6 
Agricultural runoff 1.1 4.5 13.3 NA NA 0.1 0.9 NA NA 1.8 
 
 Sampling Location Ranitidine Salbutamol Sulfamethoxazole TCEP Trimethoprim Warfarin Gadolinium Iodine 
Marlborough Effluent 5 1.2 2062.5 38.7 393.1 25.2 2.0 107980 
Hudson Effluent 4.4 3.1 1937.7 33.7 377.9 4 41.1 33580 
Maynard Effluent NA NA 1371.9 1.4 392.6 0.6 444.9 9760 
Upstream Westborough NA NA 136.8 6.6 27.3 8 7.4 8140 
Downstream Westborough 17.8 NA 928 19.2 NA 7.4 30.1 12300 
Downstream Marlborough 14.3 NA 231.8 6.6 351.6 10.7 9.2 13860 
Downstream Maynard NA NA NA 0.5 13.5 9.3 9.9 10660 
Downstream Hudson NA NA 192.5 13.5 108 8.3 14.3 7720 
Agricultural runoff 2.4 NA NA NA 16.2 3.2 7.9 15160 
         
Sampling Location Acetaminophen Atenolol Atorvastatin Caffeine Cimetidine Ciprofloxacin Cotinine DEET Diclofenac Diltiazem 
Marlborough Effluent NA 235.4 0.9 2.9 17 27.9 0.5 4.9 1.7 11937.6 
Hudson Effluent NA 3767.3 156.1 10.9 NA 19.3 0.4 NA 3.0 7789 
Maynard Effluent 2.6 174.8 4.9 11.5 NA 14.8 NA NA 2.1 442 
Upstream Westborough 7.1 36.4 1.8 38 NA NA NA 5.1 0.2 556.1 
Downstream Westborough NA 2.6 NA 5.5 NA NA NA 0.5 0.9 4554.3 
Downstream Marlborough NA 640.1 49 4.7 NA 17 NA 1.1 0.5 1551 
Downstream Maynard NA 40.5 NA 5.6 NA 15.3 NA 0.9 0.0 62.9 
Downstream Hudson NA 68.4 NA 7.1 NA NA NA 3.5 0.5 1482.3 
Agricultural runoff NA 35.4 2.2 7.1 NA NA NA NA 0.0 96.7 
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February 6
th
 2012 
Sampling Location Acetaminophen Atenolol Atorvastatin Caffeine Cimetidine Ciprofloxacin Cotinine DEET Diclofenac Diltiazem 
Marlborough Effluent NA 401.2 34.4 4.2 160183.9 161.1 6.1 29.8 3.6 25295.4 
Maynard Effluent 100.9 1807.1 56.2 706.8 NA 372.2 24.7 16.1 5.7 57239.5 
Upstream Westborough NA NA 17.8 2.1 NA NA 0.4 7.2 NA NA 
Downstream Westborough 4.2 229.3 10.0 0.7 33036.0 NA 9.6 8.4 4.7 26837.1 
Downstream Marlborough NA 82.0 12.0 3.0 5288.5 NA 3.0 10.1 1.2 7438.7 
Downstream Hudson 5.8 42.2 29.2 10.2 NA 8.9 1.6 5.9 0.6 3107.6 
Downstream Maynard 6.3 39.1 NA 23.0 NA NA 1.5 16.0 0.6 2779.5 
Downstream Maynard 2 7.8 43.0 NA 23.0 1023.4 94.4 1.9 11.9 0.8 1101.3 
Agricultural Runoff NA NA 0.2 NA NA NA NA 8.1 NA 13.7 
Nashoba Brook NA NA 8.6 NA 881.4 NA NA 6.6 NA 7.8 
 
 
 
 
 
 
Sampling Location Diphenhydramine Estradiol Estrone Furosemide Gemfibrozil Ibuprofen Miconazole Naproxen Primidone Propanolol 
Marlborough Effluent 49.6 NA NA 62.1 39.9 8.7 0.3 15.0 28.6 23.1 
Maynard Effluent 271.6 4.2 3.1 233.3 249.6 215.8 2.0 700.9 144.3 89.2 
Upstream Westborough NA NA NA NA 0.3 NA NA NA NA NA 
Downstream Westborough 102.7 NA NA 105.0 13.9 7.1 0.2 8.8 67.4 48.5 
Downstream Marlborough 21.7 6.4 NA 11.6 5.1 3.8 1.1 3.7 13.3 17.4 
Downstream Hudson 9.2 NA NA 2.5 7.3 3.6 NA 1.9 6.6 10.3 
Downstream Maynard 8.3 9.9 NA 1.3 11.7 6.7 NA 5.8 5.2 6.2 
Downstream Maynard 2 5.2 NA NA 0.2 11.9 9.3 0.1 6.7 7.1 5.5 
Agricultural Runoff NA NA NA NA 2.2 1.0 NA NA NA NA 
Nashoba Brook NA 3.1 0.9 NA 0.2 2.8 2.1 NA NA 5.9 
Sampling Location Ranitidine Salbutamol Sulfamethoxazole TCEP Trimethoprim Warfarin Gadolinium Iodine 
Marlborough Effluent 30.8 11.2 1754.8 30.1 456.5 9.5 11.0 102114.7 
Maynard Effluent 2.4 25.5 677.8 36.1 310.3 0.5 8.4 13234.7 
Upstream Westborough 17.6 NA 1.0 NA NA NA 7.1 7094.7 
Downstream Westborough 35.7 12.2 900.0 33.7 278.1 4.4 74.7 9834.7 
Downstream Marlborough 84.4 5.8 442.2 15.2 96.5 1.3 48.2 12294.7 
Downstream Hudson NA 4.2 194.3 4.0 42.9 NA 26.0 8374.7 
Downstream Maynard NA 4.0 117.5 6.5 24.8 0.1 19.3 7194.7 
Downstream Maynard 2 NA 3.9 110.9 2.9 24.2 0.6 20.1 6994.7 
Agricultural Runoff NA 3.4 0.4 3.3 NA NA 12.5 10054.7 
Nashoba Brook NA 3.6 3.7 2.6 NA 0.3 15.9 10334.7 
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February 28th 2012 
Sampling Location Acetaminophen Atenolol Atorvastatin Caffeine Cimetidine Ciprofloxacin Cotinine DEET Diclofenac Diltiazem 
Upstream Westborough NA 0.1 1.4 5.9 NA 34.5 0.8 3.2 0.1 NA 
Downstream Westborough  0.5 204.3 13.8 5.1 237.2 34.8 9.4 7.9 7.3 3575.1 
Westborough Effluent 2.2 384.2 22.8 4.3 508.7 113.6 18.8 2.2 13.8 3721.8 
River Sample-Agricultural Runoff 2.0 0.7 0.1 10.6 0.7 NA 0.8 3.6 NA 26.6 
Tributary 2 NA NA NA 3.9 0.1 NA 0.4 2.1 0.1 102.0 
Marlborough Effluent 1.8 404.6 55.8 8.0 830.2 90.7 12.6 214.8 4.9 6717.4 
Upstream Marlborough 0.1 45.0 2.9 9.1 31.0 NA 2.8 8.8 1.5 843.7 
Downstream Marlborough NA 59.1 2.9 13.9 83.1 NA 3.5 54.3 1.7 1619.5 
Upstream Hudson 14.9 28.2 1.1 19.5 21.4 39.0 1.9 26.4 0.9 506.6 
Downstream Hudson 7.7 28.4 0.7 16.2 14.0 NA 2.4 13.9 0.4 555.7 
Downstream Maynard 10.2 33.0 0.6 67.1 2.8 NA 3.1 9.7 0.5 660.8 
Downstream Maynard-2 11.5 35.2 1.1 40.6 5.3 NA 2.5 10.6 0.2 555.9 
Nashoba Brook NA 1.0 0.1 4.6 0.9 NA 0.2 4.1 NA 3.8 
 
Sampling Location Diphenhydramine Estradiol Estrone Furosemide Gemfibrozil Ibuprofen Miconazole Naproxen Primidone Propanolol 
Upstream Westborough NA 9.0 NA NA 0.3 1.1 7.0 NA 3.0 NA 
Downstream Westborough  107.8 NA NA 140.6 22.3 6.7 NA 10.9 77.2 52.8 
Westborough Effluent 130.5 5.6 2.0 178.1 42.9 24.9 10.4 23.8 138.9 120.8 
River Sample-Agricultural 
Runoff NA NA NA NA 0.1 2.5 NA 0.4 0.8 NA 
Tributary 2 NA 28.8 88.6 0.7 1.0 3.8 27.4 0.8 1.2 NA 
Marlborough Effluent 111.8 2.8 1.2 33.1 55.8 9.9 NA 17.2 60.0 29.5 
Upstream Marlborough 19.5 10.5 1.3 14.1 4.8 6.4 NA 3.3 19.2 13.3 
Downstream Marlborough 33.6 NA 1.4 18.5 7.8 5.9 NA 3.5 20.4 11.8 
Upstream Hudson 8.8 2.4 NA 5.5 2.9 6.9 0.9 4.2 6.1 5.7 
Downstream Hudson 12.2 17.4 NA 5.1 4.3 3.5 NA 3.4 9.0 5.8 
Downstream Maynard 17.9 20.6 24.0 1.5 7.4 10.5 15.0 7.0 12.2 4.3 
Downstream Maynard-2 12.4 NA 1.8 4.5 7.7 8.0 NA 6.0 4.4 3.1 
Nashoba Brook NA NA NA NA NA 3.2 NA 0.7 2.4 NA 
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Sampling Location Ranitidine Salbutamol Sulfamethoxazole TCEP Trimethoprim Warfarin Gadolinium Iodine 
Upstream Westborough 5.7 0.3 NA 10 NA 1.6 17.9 2685.1 
Downstream Westborough  68.8 8.4 737.4 66.8 269.9 7.2 51.0 1954.8 
Westborough Effluent 263.4 23.1 1440.9 75.7 568.4 12.8 92.2 2307.1 
River Sample-Agricultural 
Runoff 
NA 0.1 NA 10.3 0.2 NA 16.9 1404.3 
Tributary 2 NA 0.1 1.3 7.5 0.9 17.6 21.3 721.6 
Marlborough Effluent 6.5 14.3 1509.4 82.5 400.1 16.2 292.5 20929 
Upstream Marlborough 1.9 2.4 233.1 28.4 60.5 2.1 22.1 2398.8 
Downstream Marlborough 4.7 4.0 279.4 43.4 68.3 2.8 36.2 1077.6 
Upstream Hudson 2.2 1.5 139.1 18.6 36.9 1.5 30.6 1338.2 
Downstream Hudson 1.4 1.8 135.5 22.7 29.8 0.7 31.9 1180.4 
Downstream Maynard NA 1.3 111.8 23.6 22.4 34.4 28.5 886.8 
Downstream Maynard-2 1.4 0.8 101.5 19 20.8 1.4 27.1 596.9 
Nashoba Brook NA NA 1.8 4.6 NA NA 22.9 894.1 
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April 11th 2012 
Sampling Location Acetaminophen Atenolol Atorvastatin Caffeine Cimetidine Ciprofloxacin Cotinine DEET Diclofenac Diltiazem 
Upstream Westborough NA NA 0.6 13.3 4.0 1139.7 NA 17.1 NA 598.6 
Downstream Westborough  0.5 264.0 20.0 17.2 2667.6 680.4 21.0 0.9 36.8 509987.2 
Westborough WWTP Effluent NA 232.6 18.5 42.8 2783.7 537.3 17.8 0.3 44.5 515882.1 
Upstream Marlborough 0.8 59.8 1.3 13.2 93.9 221.7 5.3 13.8 6.7 160956.4 
Downstream Marlborough 2.4 103.9 4.2 9.7 216.4 165.7 5.9 32.6 8.4 254459.7 
Upstream Hudson NA 42.2 0.9 14.0 69.7 NA 4.9 64.1 4.2 101301.5 
Hudson WWTP Effluent 6.4 192.7 NA NA 6.9 36.8 27.9 NA 75.0 174509.6 
Downstream Hudson 1.2 35.7 0.3 32.0 23.2 0.9 4.9 89.5 7.8 97455.1 
Maynard WWTP Effluent 24.4 1685.3 103.2 467.5 NA 515.3 82.7 252.7 20.6 1089174.6 
Downstream Maynard 7.3 34.5 0.3 44.2 16.5 144.8 5.6 31.0 0.4 57109.3 
Nashoba Brook NA NA NA 9.1 NA NA NA 9.1 NA 1123.0 
Marlborough Effluent 0.5 572.5 43.8 17.3 1417.5 1295.5 38.7 143.3 59.6 544979.1 
Tributary 2 NA NA NA 3.4 NA NA NA 64.4 NA 264.0 
River Sample-Agricultural Runoff NA NA NA 19.0 NA NA NA 22.9 NA 1057.2 
 
Sampling Location Diphenhydramine Estradiol Estrone Furosemide Gemfibrozil Ibuprofen Miconazole Naproxen Primidone Propanolol 
Upstream Westborough 1.3 NA NA NA NA 1.8 16.3 0.4 0.2 3.1 
Downstream Westborough  106.4 4.6 NA 607.2 56.2 38.7 8.9 18.9 100.6 110.1 
Westborough WWTP Effluent 101.8 NA NA 441.3 33.6 32.5 1.1 16.6 109.5 111.4 
Upstream Marlborough 30.4 NA NA 5.2 5.8 9.2 2.4 3.3 42.0 19.7 
Downstream Marlborough 35.8 NA NA 14.5 8.3 9.2 2.7 4.0 33.6 21.6 
Upstream Hudson 13.6 7.7 NA 4.3 12.9 6.8 NA 6.5 18.7 6.5 
Hudson WWTP Effluent 51.8 24.6 NA 552.8 6.5 21.1 NA 8.6 242.3 48.0 
Downstream Hudson 15.0 NA NA 5.8 1.7 7.6 NA 2.7 23.7 8.1 
Maynard WWTP Effluent 555.4 NA 4.9 802.3 595.5 407.5 4.8 627.7 129.9 137.4 
Downstream Maynard 16.6 2777.2 37380.8 3.1 11.9 17.3 NA 10.4 15.6 4.7 
Nashoba Brook NA NA 2.3 NA NA 5.8 NA 0.2 2.5 NA 
Marlborough Effluent 65.5 4.5 NA 420.7 204.8 25.3 NA 56.2 55.2 73.2 
Tributary 2 NA 2.3 NA NA 0.2 3.4 NA 0.4 0.5 NA 
River Sample-Agricultural 
Runoff 
NA NA NA NA NA 4.4 NA 0.3 0.1 NA 
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Sampling Location Ranitidine Salbutamol Sulfamethoxazole TCEP Trimethoprim Warfarin Gadolinium Iodine 
Upstream Westborough NA 0.8 NA NA 31.5 1.1 11.8 3716.4 
Downstream Westborough  276.9 24.6 1609.2 47.4 643.9 9.4 125.6 3863.2 
Westborough WWTP Effluent 283.5 26.4 1583.3 48.6 637.8 9.1 101.0 3386.1 
Upstream Marlborough NA 5.1 502.3 22.3 125.0 3.1 30.1 2083.2 
Downstream Marlborough 7.5 7.2 514.9 21.7 128.1 3.8 41.7 3187.9 
Upstream Hudson 11.6 3.0 239.1 13.9 54.4 2.4 37.0 2252.0 
Hudson WWTP Effluent NA 31.2 1329.3 50.5 117.1 1.1 72.7 2380.5 
Downstream Hudson NA 4.0 279.4 9.1 46.5 2.3 35.6 2237.4 
Maynard WWTP Effluent 38.9 35.7 791.9 17.1 333.1 3.8 313.2 4230.2 
Downstream Maynard NA 2.2 151.7 NA 21.7 1.3 28.9 1602.4 
Nashoba Brook NA NA 2.8 NA NA NA 21.6 1785.9 
Marlborough Effluent 112.6 29.3 2106.3 33.7 663.7 15.1 42.7 23938.1 
Tributary 2 25.5 NA 1.6 NA 1.0 0.7 60.0 2945.7 
River Sample-Agricultural 
Runoff 
NA 0.2 NA NA 5.3 0.8 14.4 2321.8 
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May 10th 2012 
Sampling Location Acetaminophen Atenolol Atorvastatin Caffeine Cimetidine Ciprofloxacin Cotinine DEET Diclofenac Diltiazem 
Upstream Westborough NA NA NA 8.5 NA 195.9 0.5 NA NA 180.9 
Downstream Westborough  NA 68.8 5.3 18.4 209.4 NA 2.6 NA 3.3 199217.2 
Westborough WWTP Effluent 0.9 214.7 18.3 3.1 1093.9 NA 6.5 NA 10.5 429575.4 
River Sample-Agricultural Runoff NA NA NA 23.3 NA NA 1.7 17.7 NA 1879.4 
Tributary 2 NA 0.5 NA 7.4 NA NA 0.6 NA NA 145.3 
Marlborough West WWTP Effluent 0.7 949.7 42.0 17.6 1221.6 1499.0 25.9 17.0 7.0 964528.5 
Upstream Marlborough NA 11.0 NA 27.4 64.1 NA 2.6 NA 0.7 47016.5 
Downstream Marlborough NA 42.5 7.0 22.4 73.1 NA 3.1 NA 0.8 88943.7 
Hudson WWTP Effluent 2.3 314.7 NA 2.9 NA 860.8 14.7 1.9 15.9 193078.4 
Upstream Hudson 5.4 20.3 NA 43.6 46.3 466.1 2.7 NA 0.5 55873.4 
Downstream Hudson 6.4 24.6 NA 44.7 35.1 111.5 3.5 NA 1.0 53096.9 
Maynard WWTP Effluent 65.3 1078.1 54.7 186.0 NA 724.8 65.7 290.4 6.3 796918.3 
Downstream Maynard 21.3 21.5 NA 40.9 24.0 NA 6.2 72.9 0.4 35527.3 
Nashoba Brook NA 0.1 NA 15.2 NA NA 0.8 NA NA 606.5 
 
Sampling Location Diphenhydramine Estradiol Estrone Furosemide Gemfibrozil Ibuprofen Miconazole Naproxen Primidone Propanolol 
Upstream Westborough NA NA NA NA NA NA NA 1.1 2.3 NA 
Downstream Westborough  27.6 27.0 NA 57.9 19.8 3.2 NA 3.0 34.1 29.5 
Westborough WWTP Effluent 55.0 NA NA 136.3 48.6 10.7 NA 11.4 105.7 102.5 
River Sample-Agricultural 
Runoff 
NA 10.1 NA NA 0.2 1.2 NA 1.0 1.0 NA 
Tributary 2 NA NA NA NA NA 2.3 NA NA NA NA 
Marlborough West WWTP 
Effluent 
92.2 6.0 NA 245.4 65.0 5.6 NA 139.7 61.1 100.4 
Upstream Marlborough 7.4 NA NA  12.7 1.7 0.8 NA 1.2 12.2 5.9 
Downstream Marlborough 11.0 NA NA 0.4 2.8 0.9 NA 3.0 13.0 7.6 
Hudson WWTP Effluent 36.2 44.7 NA 139.3 3.5 1.6 0.1 10.1 122.1 68.9 
Upstream Hudson 7.5 1.9 NA 4.5 1.5 1.3 NA 6.8 6.2 4.4 
Downstream Hudson 7.3 NA NA 11.4 0.9 1.5 NA 7.1 10.1 5.7 
Maynard WWTP Effluent 300.0 24.7 NA 313.3 263.3 72.5 NA 580.0 163.0 114.3 
Downstream Maynard 10.3 NA NA 4.5 0.3 2.6 NA 6.5 10.9 2.9 
Nashoba Brook NA NA NA NA NA NA NA NA 0.2 NA 
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Sampling Location Ranitidine Salbutamol Sulfamethoxazole TCEP Trimethoprim Warfarin Gadolinium Iodine 
Upstream Westborough NA NA 0.2 0.3 0.7 NA 17.5 3459.5 
Downstream Westborough  81.9 9.3 661.4 50.5 154.9 2.1 51.7 3066.8 
Westborough WWTP Effluent 510.5 39.1 2340.3 65.9 554.6 9.2 76.5 5037.6 
River Sample-Agricultural Runoff NA NA 0.4 65.5 22.4 NA 60.0 1727.2 
Tributary 2 NA NA 1.2 12.3 20.8 NA 52.1 1187.7 
Marlborough West WWTP Effluent 289.9 46.5 1451.5 95.8 422.4 7.1 116.9 23350.9 
Upstream Marlborough 13.1 1.9 136.8 23.7 22.3 NA 42.9 2942.0 
Downstream Marlborough 22.0 3.7 180.8 25.8 34.5 0.1 48.3 2189.6 
Hudson WWTP Effluent 8.0 36.2 1195.9 41.2 109.0 NA 234.5 2780.5 
Upstream Hudson 11.1 1.6 120.6 55.2 20.1 0.5 43.3 1745.6 
Downstream Hudson 12.4 2.4 133.8 35.0 20.9 0.5 56.5 1708.9 
Maynard WWTP Effluent 12.9 20.9 1491.1 33.0 492.5 0.7 532.7 2898.0 
Downstream Maynard 8.8 2.1 107.4 21.4 13.1 0.3 33.1 1650.2 
Nashoba Brook NA NA 4.6 38.3 13.5 NA 41.8 1602.4 
 
 
 
 
 
 
 
6.4 Quadratic Model Results (Plots) 
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